Adage Capital Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

Adage Capital Partners’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500,000	Closed	-$7.76M	–	807
2019 Q4	$7.76M	Buy	+500,000	New	+$5.04M	0.02%	572
2019 Q2	–	Sell	-425,000	Closed	-$10.1M	–	774
2019 Q1	$10.1M	Sell	425,000 -300,000	-41%	-$6.14M	0.03%	522
2018 Q4	$11.9M	Hold	725,000	–	–	0.03%	464
2018 Q3	$19.2M	Buy	725,000 +25,000	+4%	+$566K	0.04%	409
2018 Q2	$16M	Sell	700,000 -170,000	-20%	-$3.71M	0.04%	459
2018 Q1	$18.5M	Hold	870,000	–	–	0.04%	418
2017 Q4	$11M	Hold	870,000	–	–	0.02%	555
2017 Q3	$13.5M	Buy	870,000 +20,000	+2%	+$243K	0.03%	509
2017 Q2	$9.95M	Buy	850,000 +100,000	+13%	+$1.24M	0.02%	566
2017 Q1	$8.8M	Buy	750,000 +300,000	+67%	+$3.44M	0.02%	557
2016 Q4	$5.6M	Buy	+450,000	New	+$5.21M	0.02%	598

Other funds holding MYOV

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Adage Capital Partners's MYOV Position: Q1 2020 in Review

Adage Capital Partners sold out of Myovant Sciences Ltd. (MYOV) in Q1 2020, closing a stake of 500,000 shares — an estimated $7.76M sold.

Adage Capital Partners first reported a position in MYOV in Q4 2016 and held it in 11 quarters. The position peaked at $19.2M in Q3 2018. 75 funds tracked by Wall St. Rank hold MYOV as of Q1 2020.

Adage Capital Partners reported no remaining Myovant Sciences Ltd. position as of Q1 2020 after selling out during the quarter.
Adage Capital Partners sold 500,000 Myovant Sciences Ltd. shares in Q1 2020, an estimated $7.76M.
Adage Capital Partners first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 11 quarters.
Adage Capital Partners's Myovant Sciences Ltd. position peaked at $19.2M in Q3 2018.
75 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2020.

Based on Adage Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.